TherapeuticsMD, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TherapeuticsMD, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-12-31 was -59.00K shares.
- TherapeuticsMD, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-09-30 was 7.00K shares, a 98.65% decline year-over-year.
- TherapeuticsMD, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-12-31 was -195.00 shares, a 101.57% decline year-over-year.
- TherapeuticsMD, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-09-30 was 517.89K shares, a 837.60% increase year-over-year.
- TherapeuticsMD, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 2.00K shares, a 99.83% decline from fiscal 2020.
- TherapeuticsMD, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 1.18M shares, a 243.60% increase from fiscal 2019.
- TherapeuticsMD, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 344.00K shares.
- TherapeuticsMD, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 102.55K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2021-12-31 | -59.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-07 | 2.00K shares 10-K · filed 2023-04-07 |
| 2021-09-30 | 7.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | |
| 2020-12-31 | -195.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | 1.18M shares 10-K · filed 2022-03-23 |
| 2020-09-30 | 517.89K shares 10-Q · filed 2020-11-09 | |
| 2020-06-30 | 313.64K shares 10-Q · filed 2020-08-07 | |
| 2019-12-31 | 12.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | 344.00K shares 10-K · filed 2022-03-23 |
| 2019-09-30 | 55.24K shares 10-Q · filed 2020-11-09 | |
| 2018-09-30 | 1.05M shares 10-Q · filed 2019-11-08 | |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | 102.55K shares 10-K · filed 2020-02-24 |
| 2017-09-30 | 2.50K shares 10-Q · filed 2017-11-07 | |
| 2017-06-30 | 5.00K shares 10-Q · filed 2017-08-03 | |
| 2017-03-31 | 95.05K shares 10-Q · filed 2017-05-03 | |
| 2016-09-30 | 10.00K shares 10-Q · filed 2017-11-07 | |
| 2016-06-30 | 77.12K shares 10-Q · filed 2017-08-03 | |
| 2016-03-31 | 340.05K shares 10-Q · filed 2017-05-03 | |
| 2015-09-30 | 95.00K shares 10-Q · filed 2015-11-05 | |
| 2015-06-30 | 366.62K shares 10-Q · filed 2015-08-07 | |
| 2015-03-31 | 11.25K shares 10-Q · filed 2015-05-07 | |
| 2014-09-30 | 64.96K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | |
| 2014-06-30 | 638.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | |
| 2014-03-31 | 90.30K shares 10-Q · filed 2015-05-07 | |
| 2013-12-31 | 75.42K shares 10-K · filed 2016-02-26 | |
| 2012-12-31 | 1.93M shares 10-K · filed 2013-03-12 | |
| 2012-09-30 | 30.68K shares 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |